GLUE

Monte Rosa Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$17.09

Market Cap

$1.11B

Beta

1.64

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+63.54%

EPS Growth (YoY)+40.78%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-2.47%

Debt / Equity0.17

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for GLUE.